Demographics, Clinical and Paraclinical Characteristics of Multiple Sclerosis in Egypt

Multiple Sclerosis Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02970370
• Other study ID #: Cairo-5-UMP
• Status: Completed
• Phase: N/A
• First received: November 18, 2016
• Last updated: November 21, 2016
• Start date: December 2015

Study information

• Verified date: November 2016
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Egypt: Institutional Review Board
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The primary study aim is to depict the demographics, clinical and para clinical features of patients attending five tertiary referral multiple sclerosis (MS) centers in Egypt.

This requires effective and unified pooled registries to extract data from with a standardized, sufficient and high quality clinical, magnetic resonance imaging (MRI) data, neurophysiological data and body fluids.

Investigators want to shed light on the challenges that face both physicians and patients in the area of "diagnosis and treatment"

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2752
• Est. primary completion date: July 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients with MS/NMOSD or their mimics who sought advice in one of our centers even once

Exclusion Criteria:

• Patients with missing data in their records that couldn't be completed

Study Design

Observational Model: Cohort

Related Conditions & MeSH terms

• Multiple Sclerosis
• Sclerosis

Intervention

Other:
• no intervention

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	portrayed phenotypes and para-clinical data of Egyptian Multiple Sclerosis Patients		6 months	Yes